Brief: SSY Group Says Benidipine Hydrochloride Obtained Approval For Registration From NMPA
06/01/2025 10:18
Jan 6 (Reuters) - SSY Group Ltd 2005.HK :
* BENIDIPINE HYDROCHLORIDE OBTAINED APPROVAL FOR
REGISTRATION FROM
NMPA OF CHINA
* NMPA APPROVAL FOR REGISTRATION OF BENIDIPINE HYDROCHLORIDE
TO
BECOME A BULK DRUG FOR PREPARATIONS ON MARKET
Further company coverage: 2005.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SSY
See all newsBrief: SSY Group Receives NMPA China Approval For Sodium Cromoglicate Eye Drops 2%
Brief: SSY Group Obtains NMPA Approval For Nimodipine Oral Solution
Brief: SSY Group Appoints Wu Heng Yao As Executive Director
Brief: SSY Group Says Ziprasidone Mesilate Receives Registration Approval In China
Hong Kong's SSY Group H1 profit rises on infusion solutions growth